Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. Drug Spending Will Increase 7.6% in 2015, Including PCSK9 Costs – CMS

This article was originally published in The Pink Sheet Daily

Executive Summary

Agency expects PCSK9 drugs for cholesterol will have relatively “modest” impact on drug spending across commercial and government payers in 2015, actuaries explain.

Advertisement

Related Content

US Retail Drug Spending Growth Slowing With No New Sovaldis In Sight

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS078750

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel